EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

03.22.19

The European Patent Office Needs to Put Lives Before Profits

Posted in Europe, Patents at 4:18 am by Dr. Roy Schestowitz

Last month: Bogus European Patents Kill Cancer Patients, But EPO Still Has the Audacity to Ride the Wave of World Cancer Day

EPO Cancer support in LinkedIn

Summary: Patents that pertain to health have always posed an ethical dilemma; the EPO apparently tackled this dilemma by altogether ignoring the rights and needs of patients (in favour of large corporations that benefit financially from poor people’s mortality)

THE European Patent Office’s (EPO) villains and the proponents of UPC have long lobbied for patent trolls and for patents on life. It’s all about money, not scientific advancement, and it’s preying on the lives of ill people.

There was some major news yesterday. Bristows’ Annsley Merelle Ward wrote about it (dubbing it “blow to SPC owners” [sic]) and the sole comment on these words was a critical one; watch these liars being challenged: “Why is 20 years of patent protection not sufficient to protect new formulations Amerikat? The risks and timelines are notably different from engaging in medicinal chemistry. Do you have economic data to support that? There are opposing interests in terms of access to medicines and the protection of national health budgets. That balance should be assessed by the legislature on the basis of economic assessments and should not be court driven on the basis of only one consideration. I think that it is a very sensible decision and an important one in terms of maintaining the correct balance in the industry.”

This has since then also been covered in Kluwer Patent Blog and there’s news that may indirectly relate to that (already included in our daily links):

  • CJEU bids farewell to SPCs for new formulations of old drugs

    The eagerly-awaited judgment of the Court of Justice of the European Union (CJEU) in the SPC referral Abraxis Bioscience (C-443/17) has been handed down today.

    In the case underlying this referral, the UK IPO had refused an SPC application filed by Abraxis Bioscience for the product “paclitaxel formulated as albumin-bound nanoparticles” (nab-paclitaxel; marketed as Abraxane®) for lack of compliance with Article 3(d) of the SPC Regulation (EC) 469/2009, given that the marketing authorization relied upon by Abraxis was not the first authorization of the active ingredient paclitaxel.

  • Stada Arz to launch generic Exforge in Europe

    Germany’s Stada Arzneimittel group says it will be one of the first manufacturers to launch generic…

Kevin E. Noonan, a proponent of patents on life, has just spoken of a new “Guidance for Industry relating to the biosimilar application process set forth in the Biologic Price Competition and Innovation Act of 2009 (BCPCIA).”

These biosimilars are essential for generics.

Is the EPO still granting patents on antibodies (see what we wrote last year: “Antibody Patents Should Not be Allowed, Nor Should CRISPR Patents”)? A few days ago this new press release said:

AroCell announced today that the patent nr. 3083698 and titled” Monoclonal Anti-TK1 Antibodies” is granted by European Patent Office and will be published on April 10, 2019

The patent is referring to AroCell’s proprietary technology of specific and sensitive immunological measurement of Thymidine Kinase 1 in serum. More specifically, the monoclonal antibody, XPA210-Ar1, is covered in the patent

“We are delighted that the EPO has granted this patent. This reinforce AroCell’s position and increases our attractiveness as a business partner. We will continue to develop our portfolio of proprietary assets to further expand its business opportunities.” Says Michael Brobjer, CEO AroCell.

This is really not my area; perhaps those who better understand the science behind it can explain to us why there are nowadays so many patents that revolve around the body’s natural immune system. Who benefits from such patents (on the whole)? Whose side has the EPO taken?

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Rebranding Malware and Spyware as 'Linux' to Dilute the Brand (and the News)

    Signal-to-noise ratio continues to be reduced, as a lot of "Linux" news has nothing to do with GNU/Linux or even with Free software



  2. Understanding Thierry Breton: In the Beginning...

    Career roundup of Thierry Breton, possibly the next EU Commissioner



  3. Startpage Has Been Delisted, But it Ought to be Blacklisted

    Startpage has just warned its fans (I am a former fan) of what Startpage itself covertly became months back



  4. IRC Proceedings: Tuesday, November 12, 2019

    IRC logs for Tuesday, November 12, 2019



  5. Links 12/11/2019: Plasma 5.17.3, More Intel Defects, Bytecode Alliance

    Links for the day



  6. You've Gotta Go When You've Gotta Go

    How most staff of the European Patent Office (EPO) feels these days



  7. Teaser: Thierry Breton and His Disquieting Past

    "The company attracted notoriety and loathing in the UK for its role in assessing disability benefit eligibility."



  8. EPO and EU: People Behind the Faces

    It’s no secret that the EPO breaks the law and European officials have taken no concrete steps to intervene; to make matters worse, potentially new EPO allies may soon be put in charge of the EU Commission



  9. Maintaining the 'Delete Github' page

    "This list really is a starting point, which can hopefully increase awareness about the issue of concern."



  10. Linux Foundation Picking Money

    The dating standards of the Linux Foundation



  11. Microsoft 'Borrows' the Linux Brand

    With help from the likes of the Linux Foundation Microsoft continues to misuse and ‘dilute’ the Linux brand (and registered trademark)



  12. EPO Corruption Compared to Cocaine Scandals in Antwerp

    Days after the Dutch protest discussion is sort of 'uncorked' regarding EPO corruption (published, as usual, in the form of anonymous comments)



  13. SUEPO Showed That the Media Won't Cover EPO Corruption Until Half the Workers March in the Streets

    What ought to have been a central (if not 'the' central) issue of debate in Europe is still being treated as borderline irrelevant or marginal



  14. Meanwhile in California

    News from California is being spun by Microsoft this week, owing to weak journalism that's more like PR than journalism



  15. Privacy-Centric Services and Even Drupal/Acquia Defect to the Camp of Mass Surveillance

    In search of money [pun intended] companies and services that are supposed to respect their customers and users turn out to be doing the opposite; this merits research and public discussions



  16. IRC Proceedings: Monday, November 11, 2019

    IRC logs for Monday, November 11, 2019



  17. Links 12/11/2019: Sparky 2019.11 Special Editions and Twisted 19.10.0 Released

    Links for the day



  18. Microsoft's Abduction of the Voice of Its Opposition Highlights the Urgency of the Movement/Campaign to Delete GitHub

    Microsoft understands that by entrapping FOSS and GNU/Linux inside proprietary software platforms like GitHub and Azure it can utilise the false perception that it somehow speaks on behalf of both (whilst attacking both)



  19. IRC Proceedings: Sunday, November 10, 2019

    IRC logs for Sunday, November 10, 2019



  20. SUEPO Protests Against Management of the European Patent Office Brought Back Discussions About Corruption

    The atmosphere at the second-largest institution in Europe has long been toxic; now it is becoming a lot more visible again and comments highlight the reasons for the cover-up (gross misuse of billions of euros)



  21. Links 11/11/2019: Linux 5.4 RC7, HandBrake 1.3.0 and Analysis of XFCE

    Links for the day



  22. Links 10/11/2019: digiKam 6.4.0, OpenMandriva Lx 4.1 Alpha and OpenZFS Plans

    Links for the day



  23. Video: Dutch Media on EPO Protest

    The new video added by SUEPO on Saturday in order to show Dutch media coverage of last week's protest in The Hague



  24. Politics in the Workplace Are Not Paradoxical and Outside the Workplace They Are Free Speech

    The safest space is one in which no other human (or creature) exists, but in reality we must make compromises and accept that not everyone will agree with us 100% of the time (so we must learn to live with that)



  25. IRC Proceedings: Saturday, November 09, 2019

    IRC logs for Saturday, November 09, 2019



  26. Thick Skin Makes Strong Communities

    Learning to coexist with people who don't agree on everything is a strength and successful societies encourage that (the alternative is blind conformity on all matters)



  27. Training (Proprietary Software) Versus Teaching (Free Software)

    Education necessitates software freedom — a fact that companies like Adobe, Apple and Microsoft try hard to distract from



  28. The Linux Foundation Brought as Keynote Speakers People Vastly Worse Than Those Whom It Now 'Cancels' for Purely Political Reasons

    A lot of people are very upset about the Linux Foundation's alleged 'witch-hunt' and even press coverage has caught up with the outrage; but our position is that it distracts from vastly bigger Linux Foundation scandals



  29. An Open Letter to Richard Stallman

    "It's past the time for the official cornerstones of the Free software movement to return to their full operational capacity, and to take the gear out of neutral."



  30. Links 9/11/2019: Linux Journal Goes Dark (Offline), KStars 3.3.7, OpenSUSE Name Change Aborted

    Links for the day


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts